Congenital Generalized Lipodystrophy (CGL)

Congenital Generalized Lipodystrophy(来自ICD-11)
别称:
Berardinelli-Seip Congenital Lipodystrophy
Berardinelli-Seip Syndrome
Bscl
Lipodystrophy, Congenital Generalized
Generalized Lipodystrophy
Lipoatrophic Diabetes
Cgl
Congenital Generalized Lipodystrophy Type 2
Lipodystrophy, Generalized, Congenital
Familial Partial Lipodystrophy, Type 2
Familial Generalized Lipodystrophy
Lipoatrophic Diabetes Mellitus
Total Lipodystrophy
Brunzell Syndrome
Seip Syndrome
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Congenital Generalized Lipodystrophy, also known as berardinelli-seip congenital lipodystrophy, is related to lipodystrophy, congenital generalized, type 4 and lipodystrophy, congenital generalized, type 3, and has symptoms including myalgia An important gene associated with Congenital Generalized Lipodystrophy is AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2), and among its related pathways/superpathways are Metabolism and IL-9 Signaling Pathways. The drugs Propoxycaine and Anesthetics have been mentioned in the context of this disorder. Affiliated tissues include skin and liver, and related phenotypes are hepatomegaly and lipodystrophy
查看原文 参与反馈

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Newborn
<1/1000000
49
549
2

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top